Sync: add healthcare compliance notes
This commit is contained in:
28
wiki/entities/DXY.md
Normal file
28
wiki/entities/DXY.md
Normal file
@@ -0,0 +1,28 @@
|
||||
---
|
||||
title: "DXY(丁香园)"
|
||||
type: entity
|
||||
tags: [platform, healthcare, china]
|
||||
sources: [healthcare-marketing-compliance]
|
||||
last_updated: 2026-04-25
|
||||
---
|
||||
|
||||
## Overview
|
||||
丁香园(Dingxiang Yuan / DXY),中国最大的医师专业社区平台,同时运营丁香医生(面向大众的健康科普平台)和丁香通(医药企业营销平台)。在医疗营销合规中承担医师认证体系建设和健康科普内容专业审核职能。
|
||||
|
||||
## Key Roles
|
||||
- **互联网医疗平台合规**:医师入驻资质审核(须提交医师资格证+执业证)、患者评价管理、图文/视频问诊标准
|
||||
- **健康科普内容专业审核**:健康教育内容须基于循证医学,引用文献须注明来源
|
||||
- **商业合作与编辑独立性分离**:商业合作内容须标注,编辑内容须保持独立性
|
||||
- **保健食品合规内容平台**:在健康内容中不得嵌入产品推广
|
||||
|
||||
## Role in Healthcare Marketing Compliance
|
||||
- 健康教育内容与广告边界——不得在科普文章中嵌入产品推广
|
||||
- 医师个人品牌合规——医师须以真实身份出现,展示医师资格证和执业证
|
||||
- 商业合作内容须标注"广告"或"推广"标签
|
||||
|
||||
## Aliases
|
||||
- 丁香园
|
||||
- Dingxiang Yuan
|
||||
- Dingxiang Doctor
|
||||
- 丁香医生
|
||||
- 丁香通
|
||||
39
wiki/entities/Douyin.md
Normal file
39
wiki/entities/Douyin.md
Normal file
@@ -0,0 +1,39 @@
|
||||
---
|
||||
title: "Douyin(抖音)"
|
||||
type: entity
|
||||
tags: [platform, healthcare, china, social-media]
|
||||
sources: [healthcare-marketing-compliance]
|
||||
last_updated: 2026-04-25
|
||||
---
|
||||
|
||||
## Overview
|
||||
抖音(Douyin),字节跳动旗下短视频平台,中国最大的短视频/直播平台之一。在医疗健康内容合规中具有特殊地位——医疗行业广告须满足行业准入标准,认证医师账号须遵守严格的直播和内容规则。
|
||||
|
||||
## Healthcare Industry Access Requirements
|
||||
- 须提交《医疗机构执业许可证》或药品/医疗器械资质文件进行行业认证
|
||||
- 认证后方可发布医疗健康相关内容和广告
|
||||
|
||||
## Content Review Rules
|
||||
- 禁止展示外科手术过程
|
||||
- 禁止使用患者推荐/见证疗效内容
|
||||
- 禁止展示处方药信息
|
||||
- 健康科普内容须经平台人工审核
|
||||
|
||||
## Physician Account Certification
|
||||
- 须提交医师资格证
|
||||
- 认证后获得"认证医师"标识
|
||||
- 认证医师可在合规范围内发布健康科普内容
|
||||
|
||||
## Livestream Restrictions
|
||||
- 医疗账号直播期间禁止推荐具体药品或治疗方案
|
||||
- 禁止进行在线诊断
|
||||
- 违反规定可能导致账号封禁或流量限制
|
||||
|
||||
## Advertising Placement
|
||||
- 医疗广告须经过行业资质审核
|
||||
- 创意内容须经平台人工审核
|
||||
|
||||
## Aliases
|
||||
- 抖音
|
||||
- Douyin
|
||||
- TikTok China
|
||||
28
wiki/entities/NMPA.md
Normal file
28
wiki/entities/NMPA.md
Normal file
@@ -0,0 +1,28 @@
|
||||
---
|
||||
title: "NMPA(国家药品监督管理局)"
|
||||
type: entity
|
||||
tags: [regulator, healthcare, china]
|
||||
sources: [healthcare-marketing-compliance]
|
||||
last_updated: 2026-04-25
|
||||
---
|
||||
|
||||
## Overview
|
||||
国家药品监督管理局(National Medical Products Administration),中国药品/医疗器械/化妆品监管核心机构,归口市场监督管理总局。负责药品注册审批、医疗器械注册审批、广告批准文号管理、药品上市后不良反应监测。
|
||||
|
||||
## Key Responsibilities
|
||||
- 药品注册分类及对应营销限制
|
||||
- 药品广告批准文号审批(有效期1年)
|
||||
- 医疗器械广告批准文号审批
|
||||
- 药品上市后不良反应监测与信息公开
|
||||
- 仿制药生物等效性认证推广规则
|
||||
|
||||
## Role in Healthcare Marketing Compliance
|
||||
- 处方药大众媒体广告禁令执法依据来源
|
||||
- 药品营销材料适应症必须与 NMPA 批准说明书一致——超范围推广属于违规
|
||||
- 仿制药营销可推广通过生物等效性研究,但不得声称"与原研药完全等效"
|
||||
- 在线售药管理依据:《药品网络销售监督管理办法》
|
||||
|
||||
## Aliases
|
||||
- 国家药品监督管理局
|
||||
- National Medical Products Administration
|
||||
- Guojia Yaopin Jiandu Guanli Ju
|
||||
26
wiki/entities/SAMR.md
Normal file
26
wiki/entities/SAMR.md
Normal file
@@ -0,0 +1,26 @@
|
||||
---
|
||||
title: "SAMR(国家市场监督管理总局)"
|
||||
type: entity
|
||||
tags: [regulator, healthcare, china]
|
||||
sources: [healthcare-marketing-compliance]
|
||||
last_updated: 2026-04-25
|
||||
---
|
||||
|
||||
## Overview
|
||||
国家市场监督管理总局(State Administration for Market Regulation),中国市场的综合监管机构,下设药品监督管理局(NMPA)。在医疗营销合规领域,SAMR 主导广告监管与执法,2021年发布的《医疗美容广告执法指南》标志着医美合规整治进入新阶段。
|
||||
|
||||
## Key Responsibilities
|
||||
- 广告监管综合执法
|
||||
- 医疗美容广告合规整治(2021年起)
|
||||
- 保健食品"蓝帽子"注册标志管理
|
||||
- 互联网广告管理办法执法
|
||||
|
||||
## Role in Healthcare Marketing Compliance
|
||||
- 2021年发布《医疗美容广告执法指南》,明确医美广告监管重点
|
||||
- 医疗广告须经省级卫生行政部门审查,但 SAMR 负责广告内容执法
|
||||
- 保健食品无"蓝帽子"标志不得以保健品名义销售或推广
|
||||
- 互联网广告(抖音/小红书/微信等平台)内容合规由 SAMR 监管
|
||||
|
||||
## Aliases
|
||||
- 国家市场监督管理总局
|
||||
- State Administration for Market Regulation
|
||||
40
wiki/entities/The-Agency.md
Normal file
40
wiki/entities/The-Agency.md
Normal file
@@ -0,0 +1,40 @@
|
||||
---
|
||||
title: "The Agency"
|
||||
type: entity
|
||||
tags: [multi-agent, open-source, ai-agents]
|
||||
sources: [contributing, contributing_zh-cn, specialized-workflow-architect, agentic-identity-trust, specialized-document-generator, government-digital-presales-consultant, healthcare-marketing-compliance, specialized-civil-engineer, specialized-cultural-intelligence-strategist]
|
||||
last_updated: 2026-04-25
|
||||
---
|
||||
|
||||
## Definition
|
||||
The Agency 是一个开源的多智能体(Multi-Agent)系统,提供了 147 个专业 Agent,涵盖 12 个业务部门:Engineering、Design、Finance、Game Dev、Marketing、Paid Media、Product、Project Management、Testing、Support、Spatial Computing、Specialized。
|
||||
|
||||
## Structure
|
||||
|
||||
### Departments
|
||||
| 部门 | 职能 | 代表 Agent |
|
||||
|------|------|-----------|
|
||||
| Specialized | 垂直领域专家 | [[Cultural Intelligence Strategist]]、Civil Engineer、Document Generator |
|
||||
| Engineering | 软件开发 | Backend Architect、Reality Checker、API Tester |
|
||||
| Design | 视觉与体验设计 | [[ArchitectUX]]、Brand Guardian、UX Researcher |
|
||||
| Project Management | 项目组合管理 | Studio Producer、Senior PM、Jira Workflow Steward |
|
||||
| Spatial Computing | XR/AR/VR | XR Interface Architect、visionOS Engineer |
|
||||
| Paid Media | 广告投放 | PPC Strategist、Programmatic Buyer |
|
||||
| Marketing | 内容与增长 | Content Creator、Growth Hacker |
|
||||
| Product | 产品策略 | Product Manager、Trend Researcher |
|
||||
| Testing | 质量保障 | Accessibility Auditor、Performance Benchmarker |
|
||||
| Support | 客户支持 | Support Responder、Analytics Reporter |
|
||||
|
||||
### Core Principles
|
||||
- **鲜明性格**:每个 Agent 都有明确的个性,而非泛化的人设
|
||||
- **明确交付物**:真实代码、模板、量化指标
|
||||
- **可验证工作流**:经过实践检验的操作流程
|
||||
- **学习与记忆**:持续更新领域知识
|
||||
|
||||
## Key Files
|
||||
- `Agent/agency-agents/`:所有 Agent 定义文件
|
||||
- `SPEC.md`:Agent 设计规范
|
||||
|
||||
## Related
|
||||
- [[Multi-Agent-System-Reliability]]:The Agency 的可靠性架构模式
|
||||
- [[Multi-Agent-Team]]:多 Agent 团队配置最佳实践
|
||||
39
wiki/entities/Xiaohongshu.md
Normal file
39
wiki/entities/Xiaohongshu.md
Normal file
@@ -0,0 +1,39 @@
|
||||
---
|
||||
title: "Xiaohongshu(小红书)"
|
||||
type: entity
|
||||
tags: [platform, healthcare, china, social-media]
|
||||
sources: [healthcare-marketing-compliance]
|
||||
last_updated: 2026-04-25
|
||||
---
|
||||
|
||||
## Overview
|
||||
小红书(Xiaohongshu / Little Red Book),中国领先的生活方式分享社区,以 UGC(用户生成内容)为核心,医美内容曾是平台热门品类。2021年起平台大规模清理违规医美内容,医疗健康内容现已纳入白名单管理。
|
||||
|
||||
## Healthcare Content Controls
|
||||
- **2021年起大规模医美内容清理**:平台对医疗美容内容实施严格管控
|
||||
- **白名单管理制度**:医疗健康内容须经平台认证方可发布
|
||||
- **禁止内容**:医美前后对比照片/视频("医美日记")、处方药推荐、未经验证的民间偏方
|
||||
|
||||
## Healthcare Certified Accounts
|
||||
- 医疗机构须完成专业资质认证方可发布医疗内容
|
||||
- 医师须提交医疗机构执业许可证等资质文件
|
||||
|
||||
## Brand Collaboration Compliance(蒲公英平台)
|
||||
- 医疗健康相关商业合作须通过官方平台进行
|
||||
- 内容须标注"广告"或"推广"标签
|
||||
- 违规商业合作可能导致品牌方和博主账号双重处罚
|
||||
|
||||
## Community Guidelines
|
||||
- 反对伪科学内容
|
||||
- 反对引发健康焦虑的内容
|
||||
- 用户分享的医美经历(即使"自愿分享")平台和诊所均可被追究连带责任
|
||||
|
||||
## Key Risk
|
||||
> "医美日记类内容无论是否由用户'自愿'分享,平台和诊所均可被追究连带责任。" — 2021年医美合规整治后明确
|
||||
|
||||
## Aliases
|
||||
- 小红书
|
||||
- Xiaohongshu
|
||||
- Little Red Book
|
||||
- 蒲公英平台(Pugongying)
|
||||
- Dandelion(蒲公英英文)
|
||||
Reference in New Issue
Block a user